选择性血清素再吸收抑制剂 (SSRI) 单独和与β-阻断剂结合用于治疗恐慌障碍的比较:前性队列研究
Doaa Bajabir1, Abdullah Alsubhi2, Saja A Felimban2
1Psychiatry, Medical Cities Program, Ministry of Interior, Riyadh, SAU.
Cureus
|October 8, 2024
概括
这项研究发现,单独使用选择性血清素再吸收抑制剂 (SSRI) 与SSRI与β-阻断剂结合治疗恐慌症没有显著差异. 由于组合治疗组的症状严重程度更高的趋势,需要进一步的研究.
科学领域:
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 恐慌症影响全球1.6%至2.2%的人口.
- 选择性血清素再吸收抑制剂 (SSRI) 是一线治疗方法,但症状恶化是一个挑战.
- 有限的研究将SSRI单疗法与联合SSRI和β抑制剂治疗惊慌失调进行比较,特别是在沙特阿拉伯.
研究的目的:
- 为了比较SSRI单疗法与SSRI和β-阻断剂联合治疗在减少恐慌症症状严重性的有效性.
- 评估沙特阿拉伯麦加国王阿卜杜勒阿齐兹医院患者对抑郁和焦虑症状的影响.
主要方法:
- 一项前性队列研究,涉及62名惊慌失调患者,分为SSRI单疗法 (n=29) 和SSRI与β抑制剂 (n=33) 组.
- 恐慌障碍严重程度尺度 (PDSS),患者健康问卷 (PHQ-9) 和一般焦虑障碍尺度 (GAD-7) 被用于三个月后的评估.
- 统计分析包括曼·惠特尼U测试,奇方测试,相对风险计算和多变量线性回归.
主要成果:
- 在SSRI单疗法 (中位数=6) 和组合疗法 (中位数=8) 组之间,PDSS得分没有统计学上显著的差异 (p=0.188).
- 在组合治疗组 (RR=1.8,p=0.077) 中观察到较高PDSS得分的趋势.
- 在抑郁症 (p=0.386) 或焦虑症 (p=0.182) 症状中没有发现显著差异.
结论:
- 结合SSRI和β抑制剂治疗与SSRI单一治疗相比,在恐慌症治疗中没有显著的疗效差异.
- 组合组中症状严重程度增加的趋势需要进一步调查.
- 限制包括小样本大小,单中心设计和短期随访;建议进行更大规模的随机对照试验.
相关概念视频
Panic Disorder
47
Panic disorder is an anxiety disorder characterized by recurrent and sudden minutes-long episodes of intense fear, known as panic attacks. These attacks may feel like heart attacks and often happen without warning or a specific cause. They can include symptoms such as rapid heart rate, shortness of breath, chest pain, trembling, sweating, dizziness, and a sense of helplessness. During a panic attack, individuals may feel as though they are experiencing a heart attack or are in a...
47
Anxiolytic Drugs: Overview
238
Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
238
Antidepressant Drugs: MAOIs and Other Agents
200
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
200
Anxiolytic Drugs: Benzodiazepines and Buspirone
563
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
563
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
540
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
540
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
328
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
328


